Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Berkshire Hathaway Inc. Increases Its Stake in DaVita HealthCare

By

Plus, there were a purchase at Achillion Pharmaceuticals, and sales at Freescale Semiconductor and Cousins Properties.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside sales and purchases filed with the SEC on Friday, July 5, 2013.

Notable Purchases:
  • Warren Buffett's holding company Berkshire Hathaway Inc. (NYSE:BRK.A) bought 639,200 shares of kidney care and dialysis company DaVita HealthCare Partners Inc (NYSE:DVA) for $73,369,512.
  • QVT Associates GP LLC bought 1,963,248 shares of infectious disease focused biopharmaceutical company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) for $12,615,808.
Notable Sales:
  • Gregg Lowe, the President and CEO of semiconductor, microcontroller, and microprocessor company Freescale Semiconductor Ltd (NYSE:FSL), sold 133,563 shares of company stock for $1,828,892.
  • Thomas Cousins, the Chairman of the real estate investment trust Cousins Properties Inc (NYSE:CUZ), sold 41,651 shares of company stock for $427,754.
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$73,369,512
2
BO
B
$12,615,808
3
CEO,CB,BO
B
$454,750
4
CEO,DIR
B
$447,600
5
O
B
$50,480
6
CIO
B
$45,100
7
BO
JB*
$28,154
8
DIR
AB
$25,000
9
VP,SO
JB*
$15,000
10
TT
B
$13,801

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
PR,CEO,DIR
AS
$1,828,892
2
CB,CEO,DIR
AS
$907,066
3
DIR
AS
$904,254
4
VP,OO
S
$683,183
5
CEO,DIR
AS
$679,812
6
CB,CEO,DIR
AS
$596,200
7
CB
AS
$427,754
8
VP,CFO
AS
$205,973
9
CFO
AS
$83,330
10
DIR
AS
$82,519

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
< Previous
  • 1
Next >
No positions in stocks mentioned.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE